文献速递中医内科中药与中成药合理使用

固肠止泻丸通过调节结肠肠道菌群保护DSS诱导的小鼠结肠炎

Guchang Zhixie Wan protects mice against dextran sulfate sodium-induced colitis through modulating the gut microbiota in colon.
PubMed 文献 · J Ethnopharmacol · 2020-05-20

固肠止泻丸(GC)是临床用于治疗结肠炎的中成药,但其具体机制尚不明确。本研究采用DSS诱导的雄性昆明小鼠结肠炎模型,灌胃给予GC(25、50、100 mg/kg)或柳氮磺吡啶(125 mg/kg)治疗7天,检测炎症因子、组织病理及肠道菌群。结果显示GC可降低促炎因子、改善结肠组织病理,并降低Turicibacter相对丰度、增加Ruminococcaceae_UCG-005相对丰度。

要点

  • GC可降低DSS结肠炎小鼠促炎因子IL-1β、IL-6、IL-8、IL-11、IL-12和TNF-α水平。
  • GC可改善结肠组织病理结构,并调节肠道菌群组成。
  • GC降低Turicibacter相对丰度,增加Ruminococcaceae_UCG-005相对丰度。

核心结论

  • GC通过改善炎症因子失衡和肠道菌群失调,显著改善DSS诱导的结肠炎小鼠健康状态。

研究设计与样本

  • 雄性昆明(KM)小鼠建立DSS诱导结肠炎模型,随机分组后分别口服柳氮磺吡啶125 mg/kg及GC 25、50、100 mg/kg,治疗7天。

主要发现

  • GC治疗后临床活动评分(CAS)证实其对结肠炎有保护作用。
  • GC降低促炎因子IL-1β、IL-6、IL-8、IL-11、IL-12和TNF-α水平,抗炎因子IL-4略升高。
  • H&E染色显示GC改善结肠组织病理结构。
  • 16S rDNA测序显示GC降低Turicibacter相对丰度,增加Ruminococcaceae_UCG-005相对丰度。

临床怎么用

  • GC在动物模型中通过调节炎症因子和肠道菌群改善结肠炎,提示其临床用于结肠炎可能涉及菌群调节机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Guchang Zhixie Wan (GC) is a traditional Chinese patent medicine used in the treatment of colitis in clinical trials. Though the notable effect of GC on colitis, the concrete mechanism of GC remain elusive. Emerging evidence showed that the imbalances of inflammatory cytokines and gut microbiota were both closely related to the initiation and progression of colitis. AIM OF THE STUDY: To elucidate the relationship between the protective effects of GC on colitis and gut microbiota. MATERIALS AND METHODS: Male Kunming (KM) mice were enrolled in our work to establish colitis model induced by dextran sulfate sodium (DSS). The colitis mice were randomly divided into different groups and treated orally with 125 mg/kg of sulfasalazine (positive control) and 25, 50, 100 mg/kg of GC for 7 days, respectively. Inflammation cytokines of IL-1β, IL-4, IL-6, IL-8, IL-11, IL-12 and TNF-α were detected by ELISA analysis and the histological changes were detected by H&E staining. Gut microbiota diversity was analyzed by 16S rDNA sequencing. Metagenomes analysis were also conducted to reflect the protective effects of GC on colitis. RESULTS: The results of CAS (Clinical Activity Score) confirmed the protective effects of GC on colitis. After administration of GC, the levels of pro-inflammatory cytokines IL-1β, IL-6, IL-8, IL-11, IL-12 and TNF-α were all decreased while the anti-inflammatory cytokines IL-4 was slightly increased, indicating that GC could down regulate pro-inflammatory cytokines. H&E staining revealed that GC could improve the histopathological structure of the colon tissue. The results of 16S rDNA sequences analysis showed that GC could decrease the relative abundance of Turicibacter and increase the relative abundance of Ruminococcaceae_UCG-005. CONCLUSION: GC greatly improve the health condition of colitis mice induced by DSS through improving the imbalances of inflammatory cytokines and gut microbiota.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Wang Z, Liang Y, Yu J, et al. Guchang Zhixie Wan protects mice against dextran sulfate sodium-induced colitis through modulating the gut microbiota in colon. J Ethnopharmacol. 2020. PMID: 32442592. doi:10.1016/j.jep.2020.112991

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。